We are live on ! Find out more
VCNX

Vaccinex, Inc. Common Stock
VCNX

Delisted

VCNX was delisted on the 17th of December, 2024.

Back to rankings

9 hedge funds and large institutions have $945K invested in Vaccinex, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

5% more capital invested

Capital invested by funds: $898K → $945K (+$47K)

18% less funds holding

Funds holding: 11 → 9 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TI
Telemetry Investments
New York
+$34.6K
2
PAM
Panagora Asset Management
Massachusetts
+$6.72K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$2.88K
4
UBS Group
UBS Group
Switzerland
+$960

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$190K
2
NC
Nexthera Capital
New York
-$62K
3
Millennium Management
Millennium Management
New York
-$12.5K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$1.92K

VCNX Hedge Fund Activity: Q1 2019 in Review

9 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Vaccinex, Inc. Common Stock (VCNX) for Q1 2019, worth a combined $945K — up 5.2% from $898K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of VCNX and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.

The largest buyer was Telemetry Investments, adding an estimated $34.6K. The largest seller was Perceptive Advisors, exiting entirely with an estimated $190K sold.

  • 9 institutional investors held Vaccinex, Inc. Common Stock (VCNX) as of Q1 2019, down from 11 in Q4 2018.
  • Funds reported $945K of Vaccinex, Inc. Common Stock stock for Q1 2019, up 5.2% quarter-over-quarter.
  • 0 funds opened new Vaccinex, Inc. Common Stock positions in Q1 2019 and 2 closed out, a net change of -2 holders.
  • The largest Vaccinex, Inc. Common Stock buyer in Q1 2019 was Telemetry Investments, an estimated $34.6K added.
  • The largest Vaccinex, Inc. Common Stock seller in Q1 2019 was Perceptive Advisors, an estimated $190K sold.

Based on aggregated 13F filings for Q1 2019.